Bridgefront Capital’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $750K | Sell |
48,483
-955
| -2% | -$14.8K | 0.2% | 168 |
|
|
2025
Q1 | $735K | Buy |
49,438
+8,040
| +19% | +$120K | 0.21% | 149 |
|
|
2024
Q4 | $548K | Sell |
41,398
-4,859
| -11% | -$64.3K | 0.18% | 176 |
|
|
2024
Q3 | $658K | Buy |
46,257
+24,884
| +116% | +$354K | 0.25% | 122 |
|
|
2024
Q2 | $277K | Buy |
21,373
+1,095
| +5% | +$14.2K | 0.12% | 319 |
|
|
2024
Q1 | $282K | Sell |
20,278
-522
| -3% | -$7.25K | 0.21% | 204 |
|
|
2023
Q4 | $297K | Sell |
20,800
-3,135
| -13% | -$44.7K | 0.22% | 173 |
|
|
2023
Q3 | $370K | Buy |
+23,935
| New | +$370K | 0.26% | 142 |
|
|
2021
Q3 | – | Sell |
-11,863
| Closed | -$200K | – | 645 |
|
|
2021
Q2 | $200K | Buy |
+11,863
| New | +$200K | 0.08% | 510 |
|
|
2021
Q1 | – | Sell |
-13,444
| Closed | -$245K | – | 910 |
|
|
2020
Q4 | $245K | Buy |
+13,444
| New | +$245K | 0.08% | 448 |
|